Study: CAIRE’s FreeStyle Comfort effective
By HME News Staff
Updated 10:52 AM CDT, Thu March 31, 2022
BALL GROUND, Ga. – CAIRE’s FreeStyle Comfort portable oxygen concentrator outperformed other market leading devices in a recent study designed to assess the effectiveness of these devices in delivering oxygen to patients. “Portable oxygen concentrators are intended to allow patients to maintain a more active lifestyle despite the constraints which COPD or other respiratory conditions might introduce,” said Barry hassett, vice president of global marketing. “The FreeStyle Comfort was specifically designed to optimize oxygen delivery in situations where the patient is not at rest in order to enable them to comfortably enjoy life outside the home.” Researchers at the Department of Respiratory Therapy, Byrdine F. Lewis College of Nursing and Health Professions, at Georgia State University in Atlanta compared the oxygen output of eight competitive devices that currently comprise the majority of the portable oxygen therapy market, along with control group systems, including a stationary oxygen concentrator and wall output oxygen similar to what a patient would receive in a clinical environment. Each device was assessed on its ability to deliver oxygen in a variety of situations intended to model real-life use. The GSU study demonstrated the CAIRE FreeStyle Comfort achieved higher FiO2 in seven out of the eight scenarios. FiO2 is defined as the percentage or concentration of oxygen a person inhales.
Comments